Publication:
Therapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-based strategies for treating neuroinflammation and promoting tissue repair

Simple item page
dc.contributor.authorCarbone, Javier
dc.contributor.authorFontecilla, Javiera
dc.contributor.authorSales, Nicolás
dc.contributor.authorChaparro, William
dc.contributor.authorMolina, Alfredo
dc.contributor.authorRuete, María
dc.contributor.authorGonzález, Pablo
dc.contributor.authorMachuca, Mayra
dc.contributor.authorOpazo, Ma Cecilia
dc.contributor.authorEzquer, Marcelo
dc.contributor.authorDuarte, Luisa
dc.date.accessioned2026-07-29T22:25:02Z
dc.date.available2026-07-29T22:25:02Z
dc.date.issued2025
dc.description.abstractAlthough significant progress has been made in medicine and antimicrobial research, viral infections continue to pose a critical global health challenge, particularly when they involve the central nervous system (CNS). Despite advances in vaccines, antiviral agents, and small molecule therapeutics, current strategies remain insufficient to address the complex consequences of many CNS infections fully. Notably, many viruses are neurotropic and can invade the CNS, triggering infectious neuroinflammation that often lead to chronic neurological disorders and lasting morbidity. Current therapeutic approaches are largely ineffective in preventing or reversing this long-term neurological damage, underscoring the urgent need for innovative prophylactic and therapeutic interventions. Mesenchymal stem cells (MSCs) have emerged as a promising strategy to counteract chronic neuroinflammation and promote tissue repair following viral CNS infections. This review provides a comprehensive overview of CNS viral infection and neuroinflammation, including epidemiology and pathophysiology, and critically examines the limitations of existing treatments, particularly their inability to mitigate persistent neurological sequelae. Furthermore, we summarize recent preclinical and clinical studies investigating the use of MSCs in the context of CNS viral infections, highlighting their immunomodulatory and neuroprotective mechanisms, and discuss the challenges and future directions for MSC-based therapies in clinical settings.
dc.description.versionVersión Publicada
dc.identifier.citationCarbone-Schellman J, Fontecilla-Escobar J, Sales-Salinas N, Chaparro-Pico WF, Molina-Berríos A, Ruete MC, González PA, Machuca MA, Opazo MC, Ezquer ME, Duarte LF. Therapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-based strategies for treating neuroinflammation and promoting tissue repair. Front Immunol. 2025 Oct 29;16:1677433. doi: 10.3389/fimmu.2025.1677433
dc.identifier.doihttps://doi.org/10.3389/fimmu.2025.1677433
dc.identifier.urihttps://hdl.handle.net/11447/10938
dc.language.isoen
dc.subjectCentral nervous system (CNS)
dc.subjectExtracellular vesicle (EV)
dc.subjectMesenchymal stem cells
dc.subjectNeuroinflammation
dc.subjectNeurological and neurodegenerative diseases
dc.subjectPersistent infections
dc.subjectSecretome
dc.subjectVirus
dc.titleTherapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-based strategies for treating neuroinflammation and promoting tissue repair
dc.typeArticle
dcterms.accessRightsAcceso Abierto
dcterms.sourceFrontiers in immunology
dspace.entity.typePublication
relation.isAuthorOfPublication9cd4a8e6-6ba1-4344-80a2-45c260864d4c
relation.isAuthorOfPublication.latestForDiscovery9cd4a8e6-6ba1-4344-80a2-45c260864d4c

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Therapeutic challenges in central.pdf
Size:
61.78 MB
Format:
Adobe Portable Document Format
Description:
Texto Completo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
347 B
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services